Implementing an IGRA (interferon-gamma release assay) based TB screening pathway prior to starting biological treatments – Experience from a UK university hospital Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
The changing indications for IGRA testing and impact on TB services in a UK district general hospital Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013
Utility of a T-cell interferon-gamma release assay for the diagnosis of tuberculous serositis: A prospective study in Beijing, China Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
Use of an ELISPOT interferon-gamma release assay for screening of end-stage renal failure contacts in haemodialysis centres Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014
A retrospective study of the indications for the use of interferon gamma release assays (IGRA) in a United Kingdom (UK) district general hospital (DGH) tuberculosis (TB) clinic Source: International Congress 2015 – Screening strategies in TB Year: 2015
Retrospective study of interferon gamma release assays (IGRAs) done in a district general hospital (DGH) for the screening of patients prior to biological therapies Source: International Congress 2015 – Screening strategies in TB Year: 2015
Risk of tuberculosis in dialysis population: Revising the predictive value of interferon-gamma releasing assay Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013
Outcomes of early interferon-gamma release assay (IGRA) testing in recent contacts of smear positive pulmonary tuberculosis (TB) Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013
The value of immunological methods in the diagnosis of tuberculosis in patients with HIV Source: International Congress 2015 – Screening strategies in TB Year: 2015
Latent TB infection in health care TB workers Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014
Diagnosis of latent tuberculosis infection in children with the useof different immunological methods Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Use of an interferon-gamma release assay for tuberculosis infection in an inner London HIV clinic Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009
Screening of HIV positive TB contacts with an interferon-gamma release assay in a congregate setting in Singapore Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011
New-immigrant screening for latent tuberculosis infection: Reasons for non-treatment Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis Year: 2013
Prevention of latent TB reactivation in rheumatology patients prior to anti-TNF therapy: Evaluation of a risk stratification strategy in a low prevalence area Source: International Congress 2015 – Screening strategies in TB Year: 2015
Clinical evaluation of IP-10 and MIG including IGRAs (QFT and T-SPOT) for the diagnosis of tuberculosis infection Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014
Risk factors for latent tuberculosis infection in close contacts of active tuberculosis patients in South Korea Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013
Clinical evaluation of several biomarkers including IFN-γ for the diagnosis of tuberculosis infection Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Additional analysis of antigen-specific Interleukin-2 release does not improve the performance of IGRAs for the differentiation of different states of mycobacterium tuberculosis infection Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014